GSK, Zhifei to co-promote Shingrix in $3.05B China deal, with option to expand to RSVnews2023-10-09T10:44:22+00:00October 9th, 2023|Endpoints News|
Antimicrobial resistance biotech secures $37M with ex-CureVac CEO Franz-Werner Haas at the helmnews2023-10-09T08:00:22+00:00October 9th, 2023|Endpoints News|
Bristol Myers to buy Mirati Therapeutics for $4.8Bnews2023-10-08T22:13:55+00:00October 8th, 2023|Endpoints News|
Pioneers of mRNA win Nobel — plus our interview; Eli Lilly’s M&A, leadership shuffle; UniQure layoffs as gene therapy players adapt; and morenews2023-10-07T10:00:48+00:00October 7th, 2023|Endpoints News|
Galderma renews annual breast cancer awareness campaign with personal stories of survivorsnews2023-10-06T19:04:44+00:00October 6th, 2023|Endpoints News|
CBO analysis calls for more research into savings potential for obesity treatmentsnews2023-10-06T18:51:32+00:00October 6th, 2023|Endpoints News|
Pfizer and AbbVie oral migraine drugs earn top spots with physicians, survey findsnews2023-10-06T18:50:32+00:00October 6th, 2023|Endpoints News|
Discounts for weight loss drugs are estimated at more than half, fueling questions about price, PBMs and coveragenews2023-10-06T18:34:55+00:00October 6th, 2023|Endpoints News|
Pfizer and BioNTech resolve mRNA patent lawsuit filed by Promosomenews2023-10-06T18:31:11+00:00October 6th, 2023|Endpoints News|
Arcutis wins label expansion for younger use of psoriasis cream Zoryvenews2023-10-06T18:19:52+00:00October 6th, 2023|Endpoints News|
